A subanalysis of the NeflgArd study shows benefits in eGFR and urine protein-creatinine ratio at baseline and across ...

The novel selective antibody sibeprenlimab reduced proteinuria more than any prior drug for IgA nephropathy, with excellent ...

A second-generation anti-CD40 therapy that inhibits B- and T-cell activity nearly eliminated multiple sclerosis activity over ...

Trastuzumab deruxtecan plus pertuzumab outperformed standard-of-care therapy as first-line treatment for HER2-positive ...

Wastewater monitoring helps communities spot rising outbreaks of influenza, COVID, RSV, and more. Our writer gets her feet ...

MRI visibility and the presence of secondary Gleason pattern 4 at baseline are associated with progression to treatment and ...

Significant support and follow-up’ may be necessary for older patients to implement their care plans, according to a ...

Adjunctive D-serine fails to outperform placebo in major depressive disorder but offers benefit in severe cases, especially ...

Music has shown promise in easing symptoms of neurodegenerative disease — but don’t expect a prescribed playlist anytime soon ...

But new research published in JAMA Pediatrics found distinct patterns of long COVID symptoms in young children. Researchers ...

Low-dose methotrexate for 1 year does not reduce knee pain or effusion-synovitis in patients with inflammatory knee ...

Obefazimod shows efficacy and favourable safety in patients with moderate to severely active ulcerative colitis in a 96-week ...